These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6716690)

  • 21. [Role of dietary sodium in experimental renovascular hypertension].
    Pasquié JL; Jover B; du Cailar G; Mimran A
    Arch Mal Coeur Vaiss; 1993 Aug; 86(8):1109-12. PubMed ID: 8129510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Participation of the renin-angiotensin system in experimental renovascular hypertension].
    Salazar FJ; García-Estañ J; Carbonell LF; Muñoz JA; Canteras M; Quesada T
    Rev Esp Fisiol; 1983 Jun; 39(2):161-7. PubMed ID: 6353502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influences of angiotensin on renal function in renal vascular hypertension.
    Ploth DW
    Kidney Int Suppl; 1990 Nov; 30():S97-101. PubMed ID: 2259086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renovascular hypertension.
    Textor SC
    Endocrinol Metab Clin North Am; 1994 Jun; 23(2):235-53. PubMed ID: 8070420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The renin-angiotensin system. New concepts in regulation of blood pressure and renal function.
    Goldfarb DA
    Urol Clin North Am; 1994 May; 21(2):187-94. PubMed ID: 8178386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The renin-angiotensin-aldosterone system in arterial hypertension].
    Davis JO
    Medicina (B Aires); 1979; 39 Suppl 1():8-15. PubMed ID: 398946
    [No Abstract]   [Full Text] [Related]  

  • 27. Reversal of renovascular hypertension: a comparison of changes in blood pressure, plasma renin, and sodium balance in two models in rats.
    Godfrey N; Kumar A; Bing RF; Swales JD; Thurston H
    J Lab Clin Med; 1985 Jun; 105(6):679-85. PubMed ID: 3889199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Renin-angiotensin-aldosterone system and glucocorticoids in arterial hypertension].
    Kruglova ZG; Vakulenko AD; Matveenko EG; Buiuklian AN; Ershova LM
    Sov Med; 1982; (5):27-30. PubMed ID: 7051351
    [No Abstract]   [Full Text] [Related]  

  • 29. [Renin-angiotensin system and the pathogenesis of arterial hypertension].
    Schiffrin EL; García R; Boucher R; Genest J
    Medicina (B Aires); 1979; 39(5):674-84. PubMed ID: 232741
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pathophysiology of renal hypertension].
    Scholze J; Linss G
    Z Arztl Fortbild (Jena); 1985; 79(17):711-6. PubMed ID: 3904236
    [No Abstract]   [Full Text] [Related]  

  • 31. The vasoconstriction-volume spectrum in normotension and in the pathogenesis of hypertension.
    Laragh JH; Sealey JE; Niarchos AP; Pickering TG
    Fed Proc; 1982 Jun; 41(8):2415-23. PubMed ID: 7084486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Renal artery obstruction: from experimental models to logical approach to diagnosis and treatment].
    Michel JB
    Rev Prat; 1996 May; 46(9):1077-83. PubMed ID: 8763013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Development and hemodynamic studies of a new model of experimental progressive hypertension due to restriction of the growth of the aorta in rats].
    Martín Paredero V; Millas I; Casado S; López Novoa JM
    Angiologia; 1984; 36(4):162-200. PubMed ID: 6383126
    [No Abstract]   [Full Text] [Related]  

  • 34. [Renal sequelae of sympathetic hyperactivity].
    Watschinger B; Habicht A
    Wien Med Wochenschr; 2004; 154 Spec No 1(1):7-9. PubMed ID: 15346546
    [No Abstract]   [Full Text] [Related]  

  • 35. Pediatric hypertension.
    Ingelfinger JR
    Major Probl Clin Pediatr; 1982; 24():1-297. PubMed ID: 7047912
    [No Abstract]   [Full Text] [Related]  

  • 36. [Disease model of renal hypertension].
    Suzuki H
    Nihon Rinsho; 1992 May; 50 Suppl():738-45. PubMed ID: 1513022
    [No Abstract]   [Full Text] [Related]  

  • 37. [Recent knowledge in the pathophysiology, pathogenesis and hemodynamics of arterial hypertension as a base for scientifically founded diagnosis and therapy].
    Wedler B
    Z Arztl Fortbild (Jena); 1984; 78(24):1011-8. PubMed ID: 6528646
    [No Abstract]   [Full Text] [Related]  

  • 38. Response of plasma norepinephrine levels to stimulation in renovascular hypertension.
    Waks AU; Burkhalter JF; Maxwell MH
    Mt Sinai J Med; 1984 Dec; 51(6):687-94. PubMed ID: 6396511
    [No Abstract]   [Full Text] [Related]  

  • 39. Vasodepressor mechanisms in experimental hypertension: studies using chemical medullectomy.
    Swales JD; Bing RF; Russell GI; Taverner D; Thurston H
    J Hypertens Suppl; 1986 Oct; 4(4):S43-6. PubMed ID: 3534184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atypical causes of curable renovascular hypertension: a review.
    Stair DC; Rios WA; Black HR
    Prog Cardiovasc Dis; 1990; 33(3):185-210. PubMed ID: 2236565
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.